Haemoglobin transfusion threshold in traumatic brain injury optimisation (HEMOTION): a multicentre, randomised, clinical trial protocol

Introduction Traumatic brain injury (TBI) is the leading cause of mortality and long-term disability in young adults. Despite the high prevalence of anaemia and red blood cell transfusion in patients with TBI, the optimal haemoglobin (Hb) transfusion threshold is unknown. We undertook a randomised t...

Full description

Bibliographic Details
Main Authors: Robert S Green, Dean A Fergusson, Demetrios J Kutsogiannis, Ryan Zarychanski, Kosar Khwaja, Donald Griesdale, François Lauzier, Alison Fox-Robichaud, Ian Ball, Alexis F Turgeon, John Gordon Boyd, Paul C Hébert, Shane English, Timothy Walsh, Andreas H Kramer, John C Marshall, Damon Scales, Olivier Costerousse, Annemarie Docherty, Andrea Rigamonti, Maude St-Onge, Lucy Clayton, Marie-Pier Patton, Karen E. A. Burns, Paule Lessard Bonaventure, Xavier Neveu, Vincent Laroche
Format: Article
Language:English
Published: BMJ Publishing Group 2022-10-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/10/e067117.full
_version_ 1811337311035588608
author Robert S Green
Dean A Fergusson
Demetrios J Kutsogiannis
Ryan Zarychanski
Kosar Khwaja
Donald Griesdale
François Lauzier
Alison Fox-Robichaud
Ian Ball
Alexis F Turgeon
John Gordon Boyd
Paul C Hébert
Shane English
Timothy Walsh
Andreas H Kramer
John C Marshall
Damon Scales
Olivier Costerousse
Annemarie Docherty
Andrea Rigamonti
Maude St-Onge
Lucy Clayton
Marie-Pier Patton
Karen E. A. Burns
Paule Lessard Bonaventure
Xavier Neveu
Vincent Laroche
author_facet Robert S Green
Dean A Fergusson
Demetrios J Kutsogiannis
Ryan Zarychanski
Kosar Khwaja
Donald Griesdale
François Lauzier
Alison Fox-Robichaud
Ian Ball
Alexis F Turgeon
John Gordon Boyd
Paul C Hébert
Shane English
Timothy Walsh
Andreas H Kramer
John C Marshall
Damon Scales
Olivier Costerousse
Annemarie Docherty
Andrea Rigamonti
Maude St-Onge
Lucy Clayton
Marie-Pier Patton
Karen E. A. Burns
Paule Lessard Bonaventure
Xavier Neveu
Vincent Laroche
author_sort Robert S Green
collection DOAJ
description Introduction Traumatic brain injury (TBI) is the leading cause of mortality and long-term disability in young adults. Despite the high prevalence of anaemia and red blood cell transfusion in patients with TBI, the optimal haemoglobin (Hb) transfusion threshold is unknown. We undertook a randomised trial to evaluate whether a liberal transfusion strategy improves clinical outcomes compared with a restrictive strategy.Methods and analysis HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatiON is an international pragmatic randomised open label blinded-endpoint clinical trial. We will include 742 adult patients admitted to an intensive care unit (ICU) with an acute moderate or severe blunt TBI (Glasgow Coma Scale ≤12) and a Hb level ≤100 g/L. Patients are randomly allocated using a 1:1 ratio, stratified by site, to a liberal (triggered by Hb ≤100 g/L) or a restrictive (triggered by Hb ≤70 g/L) transfusion strategy applied from the time of randomisation to the decision to withdraw life-sustaining therapies, ICU discharge or death. Primary and secondary outcomes are assessed centrally by trained research personnel blinded to the intervention. The primary outcome is the Glasgow Outcome Scale extended at 6 months. Secondary outcomes include overall functional independence measure, overall quality of life (EuroQoL 5-Dimension 5-Level; EQ-5D-5L), TBI-specific quality of life (Quality of Life after Brain Injury; QOLIBRI), depression (Patient Health Questionnaire; PHQ-9) and mortality.Ethics and dissemination This trial is approved by the CHU de Québec—Université Laval research ethics board (MP-20-2018-3706) and ethic boards at all participating sites. Our results will be published and shared with relevant organisations and healthcare professionals.Trial registration number NCT03260478.
first_indexed 2024-04-13T17:52:06Z
format Article
id doaj.art-08d78388f188440695220058ef5266a2
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2024-04-13T17:52:06Z
publishDate 2022-10-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-08d78388f188440695220058ef5266a22022-12-22T02:36:38ZengBMJ Publishing GroupBMJ Open2044-60552022-10-01121010.1136/bmjopen-2022-067117Haemoglobin transfusion threshold in traumatic brain injury optimisation (HEMOTION): a multicentre, randomised, clinical trial protocolRobert S Green0Dean A Fergusson1Demetrios J Kutsogiannis2Ryan Zarychanski3Kosar Khwaja4Donald Griesdale5François Lauzier6Alison Fox-Robichaud7Ian Ball8Alexis F Turgeon9John Gordon Boyd10Paul C Hébert11Shane English12Timothy Walsh13Andreas H Kramer14John C Marshall15Damon Scales16Olivier Costerousse17Annemarie Docherty18Andrea Rigamonti19Maude St-Onge20Lucy Clayton21Marie-Pier Patton22Karen E. A. Burns23Paule Lessard Bonaventure24Xavier Neveu25Vincent Laroche26Departments of Emergency Medicine, Dalhousie University, Halifax, Nova Scotia, CanadaClinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, CanadaDepartment of Critical Care Medicine, University of Alberta, Edmonton, Alberta, CanadaDepartment of Internal Medicine, Section of Hematology/Oncology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, CanadaDepartment of Critical Care Medicine, McGill University, Montréal, Québec, CanadaDepartment of Anesthesiology, Pharmacology, and Therapeutics, University of British Columbia, Vancouver, British Columbia, CanadaPopulation Health and Optimal Practices Research Unit (Trauma— Emergency—Critical Care Medicine), CHU de Québec-Universite Laval Research Center, Québec City, Québec, CanadaDepartment of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, CanadaDepartment of Medicine, Western University, London, Ontario, CanadaPopulation Health and Optimal Practices Research Unit (Trauma— Emergency—Critical Care Medicine), CHU de Québec-Universite Laval Research Center, Québec City, Québec, CanadaDepartment of Medicine, Division of Neurology, Queen`s University, Kingston, Ontario, CanadaDepartment of Medicine, Centre Hospitalier de l`Université de Montréal, Montréal, Québec, CanadaClinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, Ontario, CanadaCentre for Medical Informatics, Usher Institute, The University of Edinburgh, Edinburgh, UKDepartment of Critical Care Medicine, Foothills Medical Center, University of Calgary, Calgary, Alberta, CanadaInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, CanadaInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, CanadaPopulation Health and Optimal Practices Research Unit (Trauma— Emergency—Critical Care Medicine), CHU de Québec-Universite Laval Research Center, Québec City, Québec, CanadaCentre for Medical Informatics, Usher Institute, The University of Edinburgh, Edinburgh, UKInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, CanadaPopulation Health and Optimal Practices Research Unit (Trauma— Emergency—Critical Care Medicine), CHU de Québec-Universite Laval Research Center, Québec City, Québec, CanadaPopulation Health and Optimal Practices Research Unit (Trauma— Emergency—Critical Care Medicine), CHU de Québec-Universite Laval Research Center, Québec City, Québec, CanadaPopulation Health and Optimal Practices Research Unit (Trauma— Emergency—Critical Care Medicine), CHU de Québec-Universite Laval Research Center, Québec City, Québec, CanadaInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, CanadaPopulation Health and Optimal Practices Research Unit (Trauma— Emergency—Critical Care Medicine), CHU de Québec-Universite Laval Research Center, Québec City, Québec, CanadaPopulation Health and Optimal Practices Research Unit (Trauma— Emergency—Critical Care Medicine), CHU de Québec-Universite Laval Research Center, Québec City, Québec, CanadaPopulation Health and Optimal Practices Research Unit (Trauma— Emergency—Critical Care Medicine), CHU de Québec-Universite Laval Research Center, Québec City, Québec, CanadaIntroduction Traumatic brain injury (TBI) is the leading cause of mortality and long-term disability in young adults. Despite the high prevalence of anaemia and red blood cell transfusion in patients with TBI, the optimal haemoglobin (Hb) transfusion threshold is unknown. We undertook a randomised trial to evaluate whether a liberal transfusion strategy improves clinical outcomes compared with a restrictive strategy.Methods and analysis HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatiON is an international pragmatic randomised open label blinded-endpoint clinical trial. We will include 742 adult patients admitted to an intensive care unit (ICU) with an acute moderate or severe blunt TBI (Glasgow Coma Scale ≤12) and a Hb level ≤100 g/L. Patients are randomly allocated using a 1:1 ratio, stratified by site, to a liberal (triggered by Hb ≤100 g/L) or a restrictive (triggered by Hb ≤70 g/L) transfusion strategy applied from the time of randomisation to the decision to withdraw life-sustaining therapies, ICU discharge or death. Primary and secondary outcomes are assessed centrally by trained research personnel blinded to the intervention. The primary outcome is the Glasgow Outcome Scale extended at 6 months. Secondary outcomes include overall functional independence measure, overall quality of life (EuroQoL 5-Dimension 5-Level; EQ-5D-5L), TBI-specific quality of life (Quality of Life after Brain Injury; QOLIBRI), depression (Patient Health Questionnaire; PHQ-9) and mortality.Ethics and dissemination This trial is approved by the CHU de Québec—Université Laval research ethics board (MP-20-2018-3706) and ethic boards at all participating sites. Our results will be published and shared with relevant organisations and healthcare professionals.Trial registration number NCT03260478.https://bmjopen.bmj.com/content/12/10/e067117.full
spellingShingle Robert S Green
Dean A Fergusson
Demetrios J Kutsogiannis
Ryan Zarychanski
Kosar Khwaja
Donald Griesdale
François Lauzier
Alison Fox-Robichaud
Ian Ball
Alexis F Turgeon
John Gordon Boyd
Paul C Hébert
Shane English
Timothy Walsh
Andreas H Kramer
John C Marshall
Damon Scales
Olivier Costerousse
Annemarie Docherty
Andrea Rigamonti
Maude St-Onge
Lucy Clayton
Marie-Pier Patton
Karen E. A. Burns
Paule Lessard Bonaventure
Xavier Neveu
Vincent Laroche
Haemoglobin transfusion threshold in traumatic brain injury optimisation (HEMOTION): a multicentre, randomised, clinical trial protocol
BMJ Open
title Haemoglobin transfusion threshold in traumatic brain injury optimisation (HEMOTION): a multicentre, randomised, clinical trial protocol
title_full Haemoglobin transfusion threshold in traumatic brain injury optimisation (HEMOTION): a multicentre, randomised, clinical trial protocol
title_fullStr Haemoglobin transfusion threshold in traumatic brain injury optimisation (HEMOTION): a multicentre, randomised, clinical trial protocol
title_full_unstemmed Haemoglobin transfusion threshold in traumatic brain injury optimisation (HEMOTION): a multicentre, randomised, clinical trial protocol
title_short Haemoglobin transfusion threshold in traumatic brain injury optimisation (HEMOTION): a multicentre, randomised, clinical trial protocol
title_sort haemoglobin transfusion threshold in traumatic brain injury optimisation hemotion a multicentre randomised clinical trial protocol
url https://bmjopen.bmj.com/content/12/10/e067117.full
work_keys_str_mv AT robertsgreen haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT deanafergusson haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT demetriosjkutsogiannis haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT ryanzarychanski haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT kosarkhwaja haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT donaldgriesdale haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT francoislauzier haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT alisonfoxrobichaud haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT ianball haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT alexisfturgeon haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT johngordonboyd haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT paulchebert haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT shaneenglish haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT timothywalsh haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT andreashkramer haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT johncmarshall haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT damonscales haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT oliviercosterousse haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT annemariedocherty haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT andrearigamonti haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT maudestonge haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT lucyclayton haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT mariepierpatton haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT kareneaburns haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT paulelessardbonaventure haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT xavierneveu haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol
AT vincentlaroche haemoglobintransfusionthresholdintraumaticbraininjuryoptimisationhemotionamulticentrerandomisedclinicaltrialprotocol